Localised Morphea Treated Empirically with Ceftriaxone
Localised morphea is an autoimmune sclerosing disorder of unknown aetiology. Various triggering factors are known to be associated with the disease including infections, vaccination, autoimmune disorders, and trauma. Amongst the infections, the common causative organisms associated with morphea are...
Main Authors: | Deena Patil, Madivalara Yallappa Suparna, Shruthi Madhavi Govindarajulu, Tharayil Kunneth Sumathy |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2023-02-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/17549/60892_CE[Ra1]_F[SK]_PF1(PS_KM_OM)_PN(OM).pdf |
Similar Items
-
Immunohistochemical demonstration of interleukin-17 positivity in skin biopsy specimens of patients with chronic plaque psoriasis and its correlation with severity of psoriasis and associated metabolic syndrome and cardiovascular changes
by: Madivalara Yallappa Suparna, et al.
Published: (2022-01-01) -
Morphea: The 2023 update
by: Cristian Papara, et al.
Published: (2023-02-01) -
Upcoming treatments for morphea
by: Dan Wenzel, et al.
Published: (2021-12-01) -
Successful Treatment of Paediatric Morphea with Tofacitinib
by: Jun-Chi Tang, et al.
Published: (2023-04-01) -
Clinical, dermoscopic, and histopathological correlation of lichenoid dermatoses
by: Praveen Kumar Shanmugam Reddy, et al.
Published: (2019-01-01)